Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New

Abstract

Despite recent improvements in the treatment of systemic lupus erythematosus (SLE), disease activity, comorbidities and drug toxicity significantly contribute to the risk of progressive irreversible damage accrual and increased mortality in patients with this chronic disease. Moreover, even lupus patients in remission often report residual symptoms, such as fatigue, which have a considerable impact on their health-related quality of life. In recent decades, SLE treatment has moved from the use of hydroxychloroquine, systemic glucocorticosteroids and conventional immunosuppressive drugs to biologic agents, of which belimumab is the first and only biologic agent approved for the treatment for SLE to date. Novel therapies targeting interferons, cytokines and their receptors, intracellular signals, plasma cells, T lymphocytes and co-stimulatory molecules are being evaluated. In the context of a holistic approach, growing evidence is emerging of the importance of correct lifestyle habits in the management of lupus manifestations and comorbidities. The aim of this paper is to provide an overview of current pharmacological and non-pharmacological treatment options and emerging therapies in SLE.

The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations

“…GCSs have been the mainstay of SLE treatment for over 50 years and remain first arm of SLE treatment. 48 High-dose GCS or "pulse therapy" is used to rapidly control the autoimmune response during renal flares, hemolytic anemia, neuropsychiatric manifestations, among other life-threatening situations. 49 In GCS therapy, the concept of less is more proves to be true.…”

Don’t Miss Lupus

“…Many lupus patients suffer from autoimmunity that is frequently overlooked and therefore; the percentage of sufferers remains uncalculated [45]. The most common is likely Hashimoto's thyroid disease; however, other conditions include Graves' disease, myasthenia gravis, Addison's disease, primary biliary cirrhosis, and autoimmune hepatitis.…”

Systemic Lupus Erythematosus Disease: An Overview of the Clinical Approach to Pathogenesis, Diagnosis, and Treatment

“…There is no cure for SLE at present, but the condition is most often very treatable and usually responds well to some different types of drugs-especially when treatment is started in the early stages of the disease 38 . Most of the drugs described in Table III were initially developed for other diseases but were later found to be helpful in SLE 39 .…”